METHALLENESTRIL

ID: ALA1697842

Max Phase: Phase

Molecular Formula: C18H22O3

Molecular Weight: 286.37

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (3): Methallenestrol | Methallenoestril | NSC-74235
Synonyms from Alternative Forms(3):

    Canonical SMILES:  CCC(c1ccc2cc(OC)ccc2c1)C(C)(C)C(=O)O

    Standard InChI:  InChI=1S/C18H22O3/c1-5-16(18(2,3)17(19)20)14-7-6-13-11-15(21-4)9-8-12(13)10-14/h6-11,16H,5H2,1-4H3,(H,19,20)

    Standard InChI Key:  KHLJKRBMZVNZOC-UHFFFAOYSA-N

    Molecule Features

    Natural Product: YesOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 286.37Molecular Weight (Monoisotopic): 286.1569AlogP: 4.45#Rotatable Bonds: 5
    Polar Surface Area: 46.53Molecular Species: ACIDHBA: 2HBD: 1
    #RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
    CX Acidic pKa: 4.53CX Basic pKa: CX LogP: 4.72CX LogD: 1.93
    Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.88Np Likeness Score: 0.17

    References

    1. Kruhlak NL, Choi SS, Contrera JF, Weaver JL, Willard JM, Hastings KL, Sancilio LF..  (2008)  Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.,  18  (2): [PMID:20020916] [10.1080/15376510701857262]
    2. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, 
    3. WHO Anatomical Therapeutic Chemical Classification,